Transthoracic echocardiography in ACS patients in the pre-hospital emergency

Transthoracic echocardiography in ACS patients in the pre-hospital emergency - TTE_Emergency

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00004919

Enrollment

100

Registered

2013-04-29

Start date

2013-08-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myocardial infarction I20 I21

Interventions

Group 1: Presence of ACS (acute coronary syndrom): Standard procedure for NSTEMI (Non-ST-elevation myocardial infarction) > Transportation Emergency / CPU Group 2: Presence of ACS (acute coronary synd

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Be included adult patients (= 18 years) treated by the emergency physician at ACS. Planned are 100 patients, with 50 patients in the standard procedure, and 50 patients in cardiac echo examination study group

Exclusion criteria

Exclusion criteria: Exclusion criteria are: - Lack of patient consent - A history of heart attack - = Known heart failure = / > NYHA III - Previously described wall motion abnormalities in cardiac echo (post hoc exclusion)

Design outcomes

Primary

Measure	Time frame
- Compliance of identified wall motion abnormalities with ischemic area in the cardiac catheterization findings - Contact-to-balloon time with NSTEMI (Non-ST-elevation myocardial infarction)	—

Secondary

Measure	Time frame
- Incidence of NSTEMI ACS patients - Pre-clinically feasible echocardiography (examination quality) - Incidence of wall motion abnormalities in ACS patients - Incidence of other diseases diagnosed by TTE (transthoracic Echocardiography) (pleural effusion, pulmonary embolism, aortic stenosis / insufficiency, pericardial effusion) - 30 and 90 days in-hospital-mortality - Hospital days, ICU days, and monitor surveillance	—

Measure

Time frame

- Incidence of NSTEMI ACS patients - Pre-clinically feasible echocardiography (examination quality) - Incidence of wall motion abnormalities in ACS patients - Incidence of other diseases diagnosed by TTE (transthoracic Echocardiography) (pleural effusion, pulmonary embolism, aortic stenosis / insufficiency, pericardial effusion) - 30 and 90 days in-hospital-mortality - Hospital days, ICU days, and monitor surveillance

—

Countries

Germany

Contacts

Public ContactIngo Bergmann

Universitätsmedizin Göttingen Zentrum Anästhesiologie, Rettungs- und Intensivmedizin

Ingo.Bergmann@med.uni-goettingen.de0551 / 3922995

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 24, 2026